What are the appropriate next steps for a patient with a trace left pneumothorax who removed their chest tube overnight?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Immediate Chest X-Ray and Clinical Assessment

Obtain an immediate upright chest X-ray to assess the current size of the pneumothorax and determine if it has progressed since the chest tube was removed, then proceed based on clinical stability and pneumothorax size. 1

Initial Assessment Steps

  1. Assess clinical stability immediately:

    • Respiratory rate <24 breaths/min
    • Heart rate 60-120 beats/min
    • Normal blood pressure
    • Room air O2 saturation >90%
    • Patient can speak in complete sentences between breaths 1
  2. Obtain stat upright chest X-ray to determine:

    • Current pneumothorax size (apex-to-cupola distance)
    • Whether the trace pneumothorax has enlarged
    • Presence of subcutaneous emphysema

Management Algorithm Based on Findings

If Patient Remains Clinically Stable with Small Pneumothorax (<3 cm):

  • Observe in hospital for 3-6 hours 1
  • Repeat chest X-ray after observation period to exclude progression
  • If stable on repeat imaging:
    • Discharge home with close follow-up within 12-24 hours 1
    • Obtain repeat chest X-ray at follow-up
    • Provide clear instructions to return immediately if symptoms develop
  • Do NOT replace the chest tube unless the pneumothorax enlarges 1

If Patient Remains Clinically Stable but Pneumothorax is Now Large (≥3 cm):

  • Hospitalize the patient 1
  • Insert a small-bore catheter (≤14F) or 16-22F chest tube 1
  • Attach to water seal device initially; apply suction if lung fails to reexpand 1
  • This represents good consensus from the ACCP Delphi statement 1

If Patient is Clinically Unstable (Any Vital Sign Abnormality):

  • Immediate hospitalization with chest tube placement 1
  • Use 16-22F standard chest tube for most patients 1
  • Consider 24-28F tube only if anticipating large air leak or positive-pressure ventilation 1
  • Apply water seal with suction if needed 1

Key Clinical Considerations

The trace pneumothorax status before self-removal is reassuring - research demonstrates that chest tubes can be safely removed even with small residual pneumothoraces if patients meet specific criteria 2. However, the self-discontinuation bypasses the staged removal protocol that ensures air leak resolution 1.

Critical pitfall to avoid: Do not automatically replace the chest tube based solely on the fact it was self-removed. The current clinical picture and imaging dictate management, not the mechanism of tube removal. Unnecessary tube reinsertion increases pain, infection risk, and hospital stay 3, 4.

Watch for subcutaneous emphysema development - this would indicate ongoing air leak and necessitate chest tube replacement regardless of pneumothorax size.

Document the incident thoroughly and assess for underlying reasons for self-removal (pain, delirium, psychiatric issues) to prevent recurrence if tube replacement becomes necessary.

The most recent joint ERS/EACTS/ESTS guidelines 5 support conservative management for minimally symptomatic, clinically stable patients, which aligns with the older but still-relevant ACCP consensus 1. The key is matching intervention intensity to current clinical status rather than reflexively replacing the tube.

Related Questions

How long should a portable chest‑tube suction device (Pneumovac) be applied after chest tube placement for pneumothorax or air leak?
What percentage of pneumothorax cases warrant chest tube insertion?
In a patient with an active pneumothorax, should an incentive spirometer be used?
In a patient with a history of pneumothorax, is it necessary to limit exercise until the lung has fully re‑expanded and the patient is cleared by the treating physician?
How should supplemental oxygen be administered to a patient with a pneumothorax?
Which of the following agents is an antidote for cyanide poisoning: atropine, ammonia, sodium nitrate, Viagra (sildenafil), or ortho‑oxyhemoglobin?
What is the recommended carbocisteine dosing for adults with normal, mild‑to‑moderate, and severe renal impairment (creatinine clearance ≥30 mL/min versus <30 mL/min)?
What is the recommended intra‑procedural unfractionated heparin dosing and activated clotting time target for pulmonary vein isolation, how should chronic oral anticoagulation be managed before and after the ablation, and what are the alternatives for patients with heparin‑induced thrombocytopenia?
What is the mechanism by which omeprazole, a pro‑drug, enters gastric parietal (oxyntic) cells and is activated to inhibit the H⁺/K⁺‑ATPase?
What is the recommended dosing of tofisopam for anxiety and what non‑benzodiazepine alternatives should be considered?
What is the normal infrarenal aortic diameter and at what measurements does it indicate borderline enlargement, abdominal aortic aneurysm, and the need for surgical intervention?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.